A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2001
11/07/2001	CN1320610A Polypeptide-G-beta similar protein 29 and polynucleotide for coding it
11/07/2001	CN1320608A Polypeptide-laminin 16 and polynucleotide for coding it
11/07/2001	CN1320605A Anticancer precursor compound containing anthracycle cytotoxins, its preparing process and its medicine
11/07/2001	CN1320599A Limited 9-cis-isotretinoins
11/07/2001	CN1320450A Medicinal pill for clearing liver heat away, detoxication and diuresis
11/07/2001	CN1320424A Application of sodium 3,4-dihydroxycinnamate in preparing antineoplastics
11/07/2001	CN1074295C 'Sanfengkangai' capsule for treating lung cancer and its preparing process
11/07/2001	CN1074292C Cancer treating medicine capsule
11/07/2001	CN1074289C Oral liquor having functions of inhibiting tumor and regulating immunization
11/06/2001	US6313277 Breast cancer resistance protein (BCRP) and the DNA which encodes it
11/06/2001	US6313269 Tumor necrosis factor related receptor, TR6
11/06/2001	US6313264 Effector proteins of Rapamycin
11/06/2001	US6313178 For inhibit the growth of mycobacterium avium complex, in cancer therapy
11/06/2001	US6313162 Propynyl or dienyl biaromatic compounds
11/06/2001	US6313160 Substituted heterocyclic compounds, method for preparing and compositions containing same
11/06/2001	US6313158 Bioavailability of 3-heteroarylidenyl-2-indolinones active as protein tyrosine kinase inhibitors
11/06/2001	US6313156 Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
11/06/2001	US6313143 Substituted pyrroles
11/06/2001	US6313129 Therapeutic compounds
11/06/2001	US6313118 Hydroxytryptamine receptor antagonists
11/06/2001	US6313116 Phosphodiesterase inhibitors
11/06/2001	US6313109 Prenyl transferase inhibitors
11/06/2001	US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
11/06/2001	US6312939 Cells; for use in treatment of tumors, lung, breast and colon cancer and the treatment of preferential viral diseases
11/06/2001	US6312753 Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses
11/06/2001	US6312718 Liposomal composition, b-cell malignancy antigen and lipids
11/06/2001	US6312695 Isolated polypeptide with given sequence
11/06/2001	US6312694 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
11/06/2001	US6312686 Modulating the permeability of a physiological barrier with an agent that modulates tyrosine phosphorylation
11/01/2001	WO2001081928A1 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1)
11/01/2001	WO2001081918A1 Transcriptionally regulated g protein-coupled receptor g2a
11/01/2001	WO2001081622A2 Diagnosis of diseases associated with dna repair
11/01/2001	WO2001081590A2 Protein phosphatases
11/01/2001	WO2001081586A2 21657, a human short-chain dehydrogenase and uses thereof
11/01/2001	WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	WO2001081579A1 Anti-idiotype inducing antibodies, comprising at least one epitope from angiogenin, for the inhibition of angiogenesis
11/01/2001	WO2001081577A2 Dna encoding the prost 03 polypeptide
11/01/2001	WO2001081573A1 Edg8 receptor, its preparation and use
11/01/2001	WO2001081554A1 Pneumovirus ns proteins antagonising the interferon (ifn) response
11/01/2001	WO2001081551A2 Retinal pigment epithelial cell lines with extended life-span and their applications
11/01/2001	WO2001081540A2 Growth factor which acts through erb b-4 rtk
11/01/2001	WO2001081417A2 Use of taci as an anti-tumor agent
11/01/2001	WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/01/2001	WO2001081399A1 A novel polypeptide, a human pax protein 14 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081398A1 A novel polypeptide, a human pax protein 16 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081397A1 A novel polypeptide, a translation initiation factor human cofactor 81 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081396A1 A new polypeptide - human ribosomal s7 protein 14 and the polynucleotide encoding it
11/01/2001	WO2001081391A1 A novel polypeptide, a protein 29 similar to g beta and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081387A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
11/01/2001	WO2001081386A1 A novel polypeptide - human pax protein 12.5 and the polynucleotide encoding said polypeptide
11/01/2001	WO2001081385A1 A novel polypeptide, a human reductase nucleotide 9 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081384A1 A novel polypeptide-laminin 16 and the polynucleotide encoding said polypeptide
11/01/2001	WO2001081377A2 Integrin/adhesion antagonists
11/01/2001	WO2001081371A1 Gd3-mimetic peptides
11/01/2001	WO2001081363A1 Novel compounds
11/01/2001	WO2001081348A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO[3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS
11/01/2001	WO2001081342A2 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use
11/01/2001	WO2001081341A2 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
11/01/2001	WO2001081340A2 Heterocycles that are inhibitors of impdh enzyme
11/01/2001	WO2001081333A2 Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes
11/01/2001	WO2001081332A2 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
11/01/2001	WO2001081322A1 Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase
11/01/2001	WO2001081316A2 Substituted phenyl farnesyltransferase inhibitors
11/01/2001	WO2001081314A1 Naphthamidine urokinase inhibitors
11/01/2001	WO2001081312A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001	WO2001081311A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
11/01/2001	WO2001081310A1 1-aroyl-piperidinyl benzamidines
11/01/2001	WO2001080896A2 Flavopiridol drug combinations and methods with reduced side effects
11/01/2001	WO2001080890A2 Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
11/01/2001	WO2001080888A2 Method for treatment of tumors using photodynamic therapy
11/01/2001	WO2001080884A1 Intrathecal administration of rituximab for treatment of central nervous system lymphomas
11/01/2001	WO2001080879A2 Colorectal cancer vaccines and diagnosis
11/01/2001	WO2001080870A2 Compositions derived from cranberry and grapefruit and therapeutic uses therefor
11/01/2001	WO2001080869A1 Minari extract for preventing the induction and metastasis of cancer by carcinogens contained in cigarette smoke, fermented foods or alcoholic drinks
11/01/2001	WO2001080868A1 Novel medicines based on sesquiterpene mixtures
11/01/2001	WO2001080842A2 Compositions comprising a methylnogarol in combination with an antiproliferative agent
11/01/2001	WO2001080840A2 Cytotoxic agents comprising single-stranded and/or looped dna
11/01/2001	WO2001080836A1 Use of particulate vectors in immunomodulation
11/01/2001	WO2001080832A2 Administration of a thiol-based chemoprotectant compound
11/01/2001	WO2001080807A2 Medicine containing polysaccharide substances for activating apoptosis
11/01/2001	WO2001060381B1 Nucleoside analogs with carboxamidine-modified bicyclic base
11/01/2001	WO2001044239A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
11/01/2001	WO2001043754A3 Pharmaceutical composition comprised of spider venoms, the production thereof, and its use for treating tumor diseases
11/01/2001	WO2001042231A3 Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors
11/01/2001	WO2001038311A3 Pyrimidine derivatives as selective inhibitors of cox-2
11/01/2001	WO2001036641A3 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO
11/01/2001	WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001	WO2001035974A3 Aplidine treatment of cancers
11/01/2001	WO2001034640A3 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
11/01/2001	WO2001032866A3 Hybrid adaptor receptors
11/01/2001	WO2001029084A3 Novel human proteins and polynucleotides encoding the same
11/01/2001	WO2001029049A3 Imidazole derivatives as phosphodiesterase vii inhibitors
11/01/2001	WO2001029025A3 Tyrosine kinase inhibitors
11/01/2001	WO2001021620A3 Amine derivatives of benzo-4,5-thieno-2,3-d pyrimidines
11/01/2001	WO2001014318A3 New effectors of dipeptidyl peptidase iv for topical use
11/01/2001	WO2001012233A3 Sustained release formulation of a peptide
11/01/2001	WO2001010847A3 Novel integrin receptor antagonists
11/01/2001	WO2001005937A3 Conversion of a watson-crick dna to a hoogsteen-paired duplex
11/01/2001	WO2000066111A9 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/01/2001	WO2000056742A9 Organic-arsenic compounds

1 ... 1776 1777 1778 1779 1780 1781 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 ... 2211